Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vera M. R. Heydendael
Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Related publications
Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
The Experience of Pain and Redness in Patients With Moderate to Severe Plaque Psoriasis
Journal of Dermatological Treatment
Dermatology
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
JAMA Dermatology
Dermatology
Medicine
Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients With Moderate-To-Severe Plaque Psoriasis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Pss15 - Budget Impact Analysis of Apremilast in Patients With Moderate-To-Severe Plaque Psoriasis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
New Polymorphisms Associated With Response to Anti-TNF Drugs in Patients With Moderate-To-Severe Plaque Psoriasis
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Psy86 - Higher Levels of Skin Clearance Are Associated With Decreased Indirect Costs Related to Productivity Loss in Patients With Moderate-To-Severe Plaque Psoriasis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science
Pss32 - Cost-Effectiveness of Brodalumab for the Treatment of Moderate to Severe Plaque Psoriasis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
